TNF and myeloid sarcoma: Inflammatory mechanisms are known to be different between the two disease phases, as demonstrated by altered serum cytokine expression in RRMS compared to progressive MS and TNF-α-induced oligodendrocyte cell death, supporting demyelination in progressive disease.26